3,4-diaminopyridine
Showing 1 - 8 of 8
Congenital Myasthenic Syndrome Trial in Sacramento (3,4-Diaminopyridine)
Available
- Congenital Myasthenic Syndrome
- 3,4-Diaminopyridine
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
Apr 18, 2022
Myasthenic Syndromes, Congenital Trial in Durham (3,4-diaminopyridine)
No longer available
- Myasthenic Syndromes, Congenital
- 3,4-diaminopyridine
-
Durham, North CarolinaDuke University Hospital
Jan 3, 2022
Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenia (CM) Trial in Portland (3,4-diaminopyridine)
No longer available
- Lambert-Eaton Myasthenic Syndrome (LEMS)
- Congenital Myasthenia (CM)
- 3,4-diaminopyridine
-
Portland, OregonOregon Health & Science University
Dec 9, 2019
Botulism Trial in Amiens (3,4-diaminopyridine)
Completed
- Botulism
- 3,4-diaminopyridine
-
Amiens, FranceCHU
Apr 27, 2016
Lambert-Eaton Myasthenic Syndrome Trial (3,4-diaminopyridine)
Completed
- Lambert-Eaton Myasthenic Syndrome
- 3,4-diaminopyridine
- (no location specified)
Mar 24, 2015
Lambert Eaton Myasthenic Syndrome (LEMS) Trial in New York (3,4-diaminopyridine)
No longer available
- Lambert Eaton Myasthenic Syndrome (LEMS)
- 3,4-diaminopyridine
-
New York, New YorkColumbia University Medical Center
Jul 17, 2013
Multiple Sclerosis Trial in Creteil, Paris, Rennes (3,4-diaminopyridine)
Completed
- Multiple Sclerosis
- 3,4-diaminopyridine
-
Creteil, France
- +3 more
Feb 18, 2011
Multiple Sclerosis, Fatigue Trial in Aarhus (3,4-diaminopyridine, Placebo)
Completed
- Multiple Sclerosis
- Fatigue
- 3,4-diaminopyridine
- Placebo
-
Aarhus, DenmarkAarhus University Hospital, Department of Neurology
Dec 12, 2007